CeriBell, Inc. (CBLL) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $39.00K; Additional Paid in Capital, Common StockUSD $387.73M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-92.00K; Retained Earnings (Accumulated Deficit)USD $-259.36M.
- 2026-03-31: Common Stock, Value, IssuedUSD $38.00K; Additional Paid in Capital, Common StockUSD $380.85M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $18.00K; Retained Earnings (Accumulated Deficit)USD $-240.09M.
- 2025-12-31: Common Stock, Value, IssuedUSD $38.00K; Additional Paid in Capital, Common StockUSD $375.50M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $159.00K; Retained Earnings (Accumulated Deficit)USD $-220.36M.
- 2025-09-30: Common Stock, Value, IssuedUSD $38.00K; Additional Paid in Capital, Common StockUSD $370.73M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $139.00K; Retained Earnings (Accumulated Deficit)USD $-206.83M.
CeriBell, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39.00K | $387.73M | $-92.00K | $-259.36M | $128.31M | 3 month · $6.00M |
| 2026-03-31 | $38.00K | $380.85M | $18.00K | $-240.09M | $140.81M | 3 month · $3.72M |
| 2025-12-31 | $38.00K | $375.50M | $159.00K | $-220.36M | $155.34M | 12 month · $12.22M |
| 2025-09-30 | $38.00K | $370.73M | $139.00K | $-206.83M | $164.08M | 3 month · $3.35M |
| 2025-06-30 | $37.00K | $365.48M | $5.00K | $-193.36M | $172.16M | 3 month · $3.17M |
| 2025-03-31 | $36.00K | $360.57M | $-6.00K | $-179.72M | $180.88M | 3 month · $2.35M |
| 2024-12-31 | $36.00K | $358.07M | (m) | $-166.94M | $191.16M | 12 month · $5.41M |
| 2024-09-30 | $6.00K | $18.38M | (m) | $-154.37M | $-135.98M | 3 month · $1.38M |
| 2024-06-30 | (m) | (m) | (m) | (m) | $-127.28M | 3 month · $1.08M |
| 2024-03-31 | (m) | (m) | (m) | (m) | $-119.90M | 3 month · $757.00K |
| 2023-12-31 | $5.00K | $14.23M | (m) | $-126.49M | $-112.25M | 12 month · $2.68M |
| 2023-09-30 | (m) | (m) | (m) | (m) | $-105.01M | 3 month · $637.00K |
| 2023-06-30 | (m) | (m) | (m) | (m) | $-98.66M | 3 month · $585.00K |
| 2023-03-31 | (m) | (m) | (m) | (m) | $-93.23M | 3 month · $711.00K |
| 2022-12-31 | (m) | (m) | (m) | (m) | $-86.40M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |